Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD.
慢性腎病患者中鈉-葡萄糖共轉運蛋白-2抑制劑和類胰高血糖素肽-1受體激動劑的停用。
J Am Soc Nephrol 2024-08-26
Predictors and Outcomes of SGLT2 Inhibitor Discontinuation in a Real-World Population after Hospitalization for Heart Failure.
SGLT2 抑制劑在心臟衰竭住院後真實世界人群中停用的預測因子和結果。
Biomedicines 2023-03-31
Discontinuation and reinitiation of SGLT-2 inhibitors and GLP-1R agonists in patients with type 2 diabetes: a nationwide study from 2013 to 2021.
2013年至2021年間糖尿病患者中SGLT-2抑制劑和GLP-1R激動劑的停藥和重新開始情況:全國性研究。
Lancet Reg Health Eur 2023-06-04
Short-term outcomes after sodium-glucose cotransporter-2 inhibitor initiation in a cohort of heart failure patients.
心衰患者中鈉葡萄糖共轉運輸蛋白-2抑制劑啟動後的短期結果。
ESC Heart Fail 2023-10-14
Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United Kingdom.
英國的一項比較性同期研究:鈉葡萄糖共同轉運蛋白-2抑製劑的停用後預測因子。
Diabetes Obes Metab 2023-11-15
No Differences in Kidney Function Decline Between People With Type 2 Diabetes Starting a Sodium-Glucose Cotransporter 2 Inhibitor or a Glucagon-like Peptide-1 Receptor Agonist: A Real-world Retrospective Comparative Observational Study.
2型糖尿病患者開始使用鈉葡萄糖共同轉運蛋白2抑製劑或葡萄糖樣胰高血糖素受體激動劑之間的腎功能下降沒有差異:一項真實世界的回顧性比較觀察研究。
Clin Ther 2024-07-04
Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes.
SGLT2 抑制劑與 GLP-1 受體激動劑在 2 型糖尿病中的腎臟與心血管效果比較。
J Am Coll Cardiol 2024-08-14
Association of kidney function with SGLT2 inhibitor discontinuation among United States Veterans.
美國退伍軍人中腎功能與 SGLT2 抑制劑停用的關聯。
Clin J Am Soc Nephrol 2024-08-21
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care.
接受常規護理的2型糖尿病患者中,使用SGLT2抑制劑或GLP-1受體激動劑的匹配隊列比較腎臟結果。
Diabetologia 2024-08-23
Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease.
鈉-葡萄糖共轉運蛋白 2 抑制劑對糖尿病及晚期慢性腎病患者心血管和腎臟結果的影響。
Diabetologia 2024-08-29